- GlobeNewswire•8 hours agoMyriad RBM Announces an Agreement with Sanofi to Measure Predictive Cardiovascular Biomarkers in Patients with Diabetes
SALT LAKE CITY, Oct. 25, 2016-- Myriad RBM, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that it will work with Sanofi, a global and diversified healthcare leader, to perform a biomarker ...
Myriad Genetics, Inc. (MYGN) is scheduled to report first-quarter fiscal 2017 results on Nov 1, after the closing bell. Let???s see how things are shaping up prior to this announcement.
- GlobeNewswire•4 days agoMyriad Genetics Inc. Forms Relationship with ION Solutions to Deliver Quality Hereditary Cancer Tests and Services to the Nation’s Largest Network of Community Oncologists
SALT LAKE CITY, Oct. 21, 2016-- Myriad Genetics, Inc., a global leader in personalized medicine, and ION Solutions, a part of AmerisourceBergen, and the largest physician services organization specializing ...
Myriad Genetics, Inc. (MYGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||19.55 x 300|
|Ask||19.57 x 200|
|Day's Range||19.52 - 19.80|
|52wk Range||17.66 - 46.24|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||11.42|
|Avg Vol (3m)||1,968,387|
|Dividend & Yield||N/A (N/A)|